Overview
Efficacy of XP20B Following Bunionectomy Surgery
Status:
Completed
Completed
Trial end date:
2008-08-01
2008-08-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to determine if XP20B is an effective treatment for the relief of pain following bunionectomy surgery.Phase:
Phase 3Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Xanodyne Pharmaceuticals
Criteria
Inclusion Criteria:- having undergone bunionectomy surgery
- having achieved the requisite level of pain
Exclusion Criteria:
- pregnant or lactating
- history of substance abuse
- clinically significant condition or lab abnormality
- taken any prohibited medications
- gastrointestinal bleeding or history of